The NCI Board of Scientific Advisors approved five Requests for Applications, as well as two Cancer Moonshot concepts, at a joint meeting with the National Cancer Advisory Board on Dec. 4, 2018.
As NCI paylines drop to 4%, cancer centers are tapping into their institutional funds to provide “bridge funding,” typically in $50,000 to $100,000 increments, to enable investigators to keep their labs open until better times return—next year God willing.
